INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
RJ

Rubin Jonathan

SVP, Chief Medical OfficerCIK 0001836067

EDGAR filingsOpen in network
Disclosed transactions19
Buys / sells0 / 0
Max Insider Score13
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    SUPERNUS PHARMACEUTICALS, INC.SVP, Chief Medical Officer · Aug 14, 2026
12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J
—
2,500 sh
Nov 2, 2026
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
1,250 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
4,250 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
70.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
14.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
15.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
25.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
25.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
20.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
25.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
20.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
13.5K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

12
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,375 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

9
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Grant or award
A—
70.0K sh
Oct 30, 2026Nov 2, 2026
traded Oct 30, 2026
+3dSEC FORM 4

Evidence

9
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Tax withholding
F$17K
363 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

9
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
750 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

13
RJ
Rubin JonathanSVP, Chief Medical Officer
SUPNSUPERNUS PHARMACEUTICALS, INC.
Option exercise
M—
750 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence